These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 30082493)

  • 1. Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?
    Natkunam Y; Gratzinger D; Chadburn A; Goodlad JR; Chan JKC; Said J; Jaffe ES; de Jong D
    Blood; 2018 Nov; 132(18):1871-1878. PubMed ID: 30082493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunodeficiency-associated lymphoid proliferations (ALPS, HIV, and KSHV/HHV8).
    Chadburn A
    Semin Diagn Pathol; 2013 May; 30(2):113-29. PubMed ID: 23537912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and management of EBV-positive lymphoproliferative disorders].
    Arai A
    Rinsho Ketsueki; 2023; 64(8):764-771. PubMed ID: 37673629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review.
    Shimoyama Y; Oyama T; Asano N; Oshiro A; Suzuki R; Kagami Y; Morishima Y; Nakamura S
    J Clin Exp Hematop; 2006 Mar; 46(1):1-4. PubMed ID: 17058802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoproliferative disorders in children with primary immunodeficiencies: immunological status may be more predictive of the outcome than other criteria.
    Canioni D; Jabado N; MacIntyre E; Patey N; Emile JF; Brousse N
    Histopathology; 2001 Feb; 38(2):146-59. PubMed ID: 11207828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological findings, prognosis, and Epstein-Barr virus infection in rheumatoid arthritis patients with other iatrogenic immunodeficiency-associated T- and NK-cell lymphoproliferative disorders.
    Kimura S; Oshiro Y; Iwasaki H; Kadowaki M; Ogata M; Daa T; Sakata T; Kawauchi S; Wang Z; Takamatsu Y; Takeshita M
    BMC Cancer; 2022 Dec; 22(1):1342. PubMed ID: 36544095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin-Limited, Methotrexate-Associated Epstein-Barr Virus-Positive Mucocutaneous Ulcer-A Mimicker of High-Grade Lymphoma. A Report of 4 Cases and Review of the Literature.
    Macklin PS; Fisher R; Stonard C; Matin RN; Ieremia E
    Am J Dermatopathol; 2023 Aug; 45(8):519-531. PubMed ID: 37462204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodeficiency-Associated Epstein-Barr Virus-Positive B-cell Lymphoproliferative Disorders: A Review and New Paradigm.
    Chapman J
    Surg Pathol Clin; 2023 Jun; 16(2):213-231. PubMed ID: 37149357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases.
    Fujimoto K; Hatanaka KC; Hatanaka Y; Kasahara I; Yamamoto S; Tsuji T; Nakata M; Takakuwa Y; Haseyama Y; Oyamada Y; Yonezumi M; Suzuki H; Sakai H; Noguchi H; Mori A; Nishihara H; Teshima T; Matsuno Y
    Hematol Oncol; 2020 Dec; 38(5):799-807. PubMed ID: 32798315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CCR4 monoclonal antibody mogamulizumab for the treatment of EBV-associated T- and NK-cell lymphoproliferative diseases.
    Kanazawa T; Hiramatsu Y; Iwata S; Siddiquey M; Sato Y; Suzuki M; Ito Y; Goshima F; Murata T; Kimura H
    Clin Cancer Res; 2014 Oct; 20(19):5075-84. PubMed ID: 25117294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iatrogenic immunodeficiency-associated lymphoproliferative disorders of B-cell type that develop in patients receiving immunosuppressive drugs other than in the post-transplant setting.
    Momose S; Tamaru JI
    J Clin Exp Hematop; 2019; 59(2):48-55. PubMed ID: 31257345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.
    Latour S; Winter S
    Front Immunol; 2018; 9():1103. PubMed ID: 29942301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.
    Knowles DM; Cesarman E; Chadburn A; Frizzera G; Chen J; Rose EA; Michler RE
    Blood; 1995 Jan; 85(2):552-65. PubMed ID: 7812011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the midfacial destructive drama to the unfolding EBV story: a short history of EBV-positive NK-cell and T-cell lymphoproliferative diseases.
    Ng CS
    Pathology; 2024 Oct; 56(6):773-785. PubMed ID: 39127542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inherited lymphoproliferative disorders].
    Kanegane H; Hoshino A
    Rinsho Ketsueki; 2019; 60(6):708-715. PubMed ID: 31281164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
    Ohshima K; Kimura H; Yoshino T; Kim CW; Ko YH; Lee SS; Peh SC; Chan JK;
    Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How I Diagnose EBV-Positive B- and T-Cell Lymphoproliferative Disorders.
    Dojcinov SD; Quintanilla-Martinez L
    Am J Clin Pathol; 2023 Jan; 159(1):14-33. PubMed ID: 36214507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders with a T- or NK-cell phenotype.
    Satou A; Tsuzuki T; Nakamura S
    J Clin Exp Hematop; 2019; 59(2):56-63. PubMed ID: 31257346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.
    Cai Q; Chen K; Young KH
    Exp Mol Med; 2015 Jan; 47(1):e133. PubMed ID: 25613730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder].
    Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.